ARCHIVES

OTA Report Concludes Prostate Screening Not Demonstrated To Save Lives

This article is from The Cancer Letter archive.

Vol. 21 No. 22 | June 2, 1995

Download PDF Visit The Full Archive

Related Articles

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000